Tag: INmune Bio
December 12, 2019
Biotech Trends 2019: M&A Slows, CNS Therapies Make Headlines
2019 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...
December 4, 2019
5 Top Biotech News Stories of 2019
The Investing News Network profiles the five top biotech news stories of the year as decided by our readers. December 2, 2019
INmune Bio Doses First Alzheimer’s Disease Patient in XPro1595 Study
The company announced that the first patient has been enrolled in its Phase 1b clinical trial in patients with Alzheimer's...
September 12, 2019
5 Alzheimer’s Disease Treatment Stocks on the NASDAQ
A report from Reports and Data suggests the overall Alzheimer's market will be worth US$12.43 billion by 2026. September 12, 2019
INmune Bio Gets US Patent for DN-TNFa Platform
INmune Bio (NASDAQ:INMB) has announced that the US Patent and Trademark Office has granted the company Patent Application Serial No.... May 15, 2019
INmune Bio Reports First Quarter 2019 Financial Results
INmune Bio (NASDAQ:INMB) has reported its financial results for the first quarter ended March 31, 2019. As quoted in the...
April 16, 2019